Want to join the conversation?
$EMN 2Q15 Q&A: Wallin of CLSA asked if there was mix in incremental margin of Advanced Materials. Mark said there is volume growth, mix and fixed cost levearage. Great EBITDA margin in this business. When delivering volume and improving mix, there is tremendous variable margin that drops to bottom line because of fixed cost leverage.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?